These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28822113)

  • 1. Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges.
    Lamsal R; Zwicker JD
    Appl Health Econ Health Policy; 2017 Dec; 15(6):763-772. PubMed ID: 28822113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations.
    Franklin M; Lomas J; Richardson G
    Pharmacoeconomics; 2020 Jul; 38(7):665-681. PubMed ID: 32291596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep Outcomes for Parents of Children With Neurodevelopmental Disabilities: A Systematic Review.
    Micsinszki SK; Ballantyne M; Cleverley K; Green P; Stremler R
    J Fam Nurs; 2018 May; 24(2):217-249. PubMed ID: 29739263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scoping review of pediatric economic evaluation 1980-2014: do trends over time reflect changing priorities in evaluation methods and childhood disease?
    Sullivan SM; Tsiplova K; Ungar WJ
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):599-607. PubMed ID: 27659998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic opportunities and challenges for pharmacogenomics.
    Deverka PA; Vernon J; McLeod HL
    Annu Rev Pharmacol Toxicol; 2010; 50():423-37. PubMed ID: 20055709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Sleep Disorders in Children With Neurodevelopmental Disorders: A Review.
    Blackmer AB; Feinstein JA
    Pharmacotherapy; 2016 Jan; 36(1):84-98. PubMed ID: 26799351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness of Four Parenting Programs and Bibliotherapy for Parents of Children with Conduct Problems.
    Sampaio F; Enebrink P; Mihalopoulos C; Feldman I
    J Ment Health Policy Econ; 2016 Dec; 19(4):201-212. PubMed ID: 27991419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should "standard gamble" and "'time trade off" utility measurement be used more in mental health research?
    Flood C
    J Ment Health Policy Econ; 2010 Jun; 13(2):65-72. PubMed ID: 20919593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The generation gap: differences between children and adults pertinent to economic evaluations of health interventions.
    Keren R; Pati S; Feudtner C
    Pharmacoeconomics; 2004; 22(2):71-81. PubMed ID: 14731049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of Community Level Interventions for Pre-eclampsia (CLIP) in South Asian and African countries: a study protocol.
    Khowaja AR; Mitton C; Bryan S; Magee LA; Bhutta ZA; von Dadelszen P
    Implement Sci; 2015 May; 10():76. PubMed ID: 26007682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of health economic evaluation within decision making in Austria.
    Zechmeister-Koss I; Stanak M; Wolf S
    Wien Med Wochenschr; 2019 Sep; 169(11-12):271-283. PubMed ID: 30868427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telemedicine for the Medicare population: pediatric, obstetric, and clinician-indirect home interventions.
    Hersh WR; Wallace JA; Patterson PK; Shapiro SE; Kraemer DF; Eilers GM; Chan BK; Greenlick MR; Helfand M
    Evid Rep Technol Assess (Summ); 2001 Aug; (24 Suppl):1-32. PubMed ID: 11569328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex interface between economy and healthcare: An introductory overview for clinicians.
    Ottolini FL; Buggio L; Somigliana E; Vercellini P
    Eur J Intern Med; 2016 Dec; 36():1-6. PubMed ID: 27577606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence.
    Tang K
    Pharmacoeconomics; 2015 Jan; 33(1):31-48. PubMed ID: 25169062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations.
    Prosser LA; Hammitt JK; Keren R
    Pharmacoeconomics; 2007; 25(9):713-26. PubMed ID: 17803331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Child psychiatry: limited research, evidence for cost-effectiveness of treatment].
    Vermeiren RM; van der Meer J
    Tijdschr Psychiatr; 2016; 58(10):728-732. PubMed ID: 27779290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of early intervention services.
    McCrone P; Knapp M
    Br J Psychiatry Suppl; 2007 Dec; 51():s19-22. PubMed ID: 18055933
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.